L

LGC Group

Sells oligos, probes, primers, viral materials

Senior Project Manager - CPQ

ContractUpdated on 10/23/2026
$124k - $184k/yr
Senior
Bachelor's
Milford, MA, USA
RemoteRemote role; project work spans the United States and EMEA.
Project & Program ManagementProject Management

About the job

Requirements
  • Formal qualification in project management at practitioner level, or an equivalent combination of relevant education and applicable work experience.
  • Track record of personally delivering complex information technology system projects to agreed scope, cost, schedule, and quality within a multi-site organisation.
  • Demonstrable experience of enterprise resource planning implementation or integration work, including interface specification, master data, data migration, and cutover.
  • Experience delivering web development projects, including requirements definition, working with development teams through iterative build, and release into live service.
  • Proven ability to represent business interests within technology delivery, translating operational needs into system requirements and challenging technical proposals that do not meet them.
  • Experience planning and running user acceptance testing, including test scripts, defect triage, and go or no-go evidence.
  • Experience of business change and adoption activity, including process updates, training delivery, and post-implementation support.
  • Experience of managing technology suppliers and development partners through to acceptance of deliverables.
  • Sufficient technical literacy to challenge and interrogate technical solutions, including application integration and interfaces, databases, and data structures, without being a hands-on developer.
  • Working knowledge of quality management systems, with experience delivering systems subject to computerised system validation, data integrity, and International Organization for Standardization or regulatory requirements.
  • Practical, hands-on planning capability, including project schedules, critical path analysis, budget tracking, and risk and issue management.
  • Strong stakeholder management at working and site level, with the ability to translate between technical and non-technical audiences and influence without direct authority.
Responsibilities
  • Take end-to-end delivery accountability for business-led projects enabled by IT solutions, including requirements gathering through build, testing, deployment, adoption, and handover into live service.
  • Act as the business's representative throughout the delivery lifecycle and, working in close partnership with the IT Technical Delivery Lead, translate operational, commercial, and quality needs into system requirements and hold internal IT teams and suppliers to agreed outcomes.
  • Own and maintain the project plan, budget, risk and issue log, and dependency list; track progress against agreed scope, cost, schedule, and quality; and report into programme governance.
  • Working with the IT Technical Delivery Lead, deliver system integration activity at project level, including interface specification, master data alignment, data migration, cutover planning, and reconciliation with business process owners.
  • Deliver web-based platform and application projects, including requirements definition, user experience and accessibility expectations, content and data ownership, and release planning.
  • Work with the IT Technical Delivery Lead to plan and run user acceptance testing, including test scripts, business tester coordination, defect triage, and evidence to support the go or no-go recommendation.
  • Identify, manage, and liaise with stakeholders impacted by initiatives to ensure alignment with business sponsors and resource allocation and engagement to deliver business benefits.
  • Deliver business change and adoption activity for assigned projects, including impact assessment, process updates, training delivery, cutover communications, and post-implementation support.
  • Manage technology suppliers and development partners engaged on the project, including scope definition, performance monitoring, change control, and acceptance of deliverables.
  • Ensure assigned projects meet the quality management system, computerised system validation, data integrity, and information security requirements applicable to a regulated life sciences environment.
  • Own and deliver concise and action-oriented project communication through regular project updates in PMO tools, steering committees, and related forums.
  • Resolve day-to-day issues and competing priorities between business functions and IT, escalating promptly to the Programme Manager or Programme Management and Operational Excellence leadership where resolution falls outside the project's authority.
  • Provide guidance and informal coaching to Project Managers and business project team members, and contribute lessons learned to Programme Management and Operational Excellence delivery frameworks, templates, and reporting.
Desired Qualifications
  • Experience managing the deployment of Configure Price Quote software solutions.
  • Degree in a scientific, engineering, business, or computing discipline.
  • Experience of a named enterprise resource planning platform, such as IFS, SAP, or Microsoft Dynamics.
  • Experience in the diagnostics, genomics, or wider life sciences industry, including laboratory or manufacturing systems such as laboratory information management systems or manufacturing execution systems.
  • Working knowledge of agile delivery frameworks and experience operating in a hybrid agile and stage-gate delivery environment.
  • Formal qualification in business analysis, or in a continuous improvement methodology such as Lean or Six Sigma.
  • Experience of working across United States and Europe, Middle East and Africa time zones with cross-functional and supplier teams.

About the company

LGC Group provides life-sciences tools and services worldwide, including oligo components, probes, primers, recombinant viral materials, and proficiency-testing schemes for food safety. Its products support vaccine development, diagnostics, and therapies through mass spectrometry, immunoassays, and nucleic acid chemistry. It differentiates itself with a broad catalog of high-quality tools plus global proficiency-testing services and a wide customer base across diagnostics, healthcare, and pharma. Its goal is to improve healthcare outcomes and help create safer vaccines and treatments by delivering reliable tools and quality services.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

London, United Kingdom

Founded

1841

Get referred to LGC Group

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • LGC opened the CAD$100 million Vaughan center in 2025, expanding pharma supply capacity.
  • DiaMex's December 2024 acquisition strengthened clinical diagnostics and genomics controls.
  • The 2026 DSIT contract and 2027 Irish horseracing renewal extend revenue visibility.

What critics are saying

  • Astorg and Cinven's 2024 acquisition increases integration pressure and leverage discipline.
  • Revelio data shows headcount fell to 3,535 by March 2026, signaling efficiency pressure.
  • A rival could displace LGC if reference-material leadership weakens after the ChromaDex integration.

What makes LGC Group unique

  • LGC's 2026 ChromaDex acquisition deepens reference materials and North American distribution.
  • The 2025 Vaughan synthesis center gives TRC large-scale chemistry capacity worldwide.
  • DSIT awarded LGC a £39.5 million direct-award contract through March 2029.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options
  • Remote Work Options

Growth & Insights and Company News

6 month growth

-8%

1 year growth

-8%

2 year growth

-8%
Samedan Ltd
Oct 12th, 2026
Trio become latest Symbiosis commercial additions.

Trio become latest Symbiosis commercial additions. Symbiosis Pharmaceutical Services has further strengthened its commercial team with three new appointments. Payal Roychoudhury and Joaquín Pérez Fornieles join the Business Development team supporting growth respectively in APAC and Southern Europe and Annie Shafran joins as Inside Sales Manager. A contract development and manufacturing organisation (CDMO), Symbiosis specialises in the aseptic manufacture and fill-finish of injectable medicines for clinical trials and commercial supply. The Stirling-based business is targetting international growth across the Southern Europe, Asia-Pacific and the Middle East territories. Joanne Anderson, Chief Commercial Officer at Symbiosis, said: "We're delighted to welcome Payal, Joaquín and Annie to the Symbiosis team. Payal and Joaquín will help us build relationships in priority international markets, while Annie's new role will strengthen the support we provide from the first client enquiry. Together, they will help more drug developers access the manufacturing capacity and expertise we have invested strongly in." Based in Glasgow, Roychoudhurywill focus on the Asia-Pacific and the Middle East territories. Fornieles, based in Málaga, Spain, has responsibility for Southern Europe and support for other European and selected markets. Shafran, based in Manchester, joins from LGC where she was a Key Account Manager working with international clients. The appointments follow the recent arrival of Jay Chima as Vice President, Business Development, and Jos Vergeest as Senior Business Development Director. Symbiosis' £26 million expansion programme, has increased its aseptic manufacturing capacity for clinical and commercial supply.

LNEG - Laboratório Nacional de Energia e Geologia
Jul 17th, 2026
LNEG and LGC are organising an international workshop on ocean-inspired strategies at SEA TECH WEEK 2026.

LNEG and LGC are organising an international workshop on ocean-inspired strategies at SEA TECH WEEK 2026. Published on 17 July, 2026 Updated on 17 July, 2026 The National Laboratory for Energy and Geology (LNEG, Lisbon) and the Laboratoire de Génie Chimique (LGC, Toulouse) are organising, as part of SEA TECH WEEK 2026, the workshop 'Marine-Inspired Strategies for Enhancing Materials Durability' (STW40), to be held on the morning of 8 October in Brest, France. SEA TECH WEEK is one of the leading international events dedicated to maritime science and technology, bringing together experts, researchers and companies from across Europe in Brest between 6 and 8 October to discuss innovation in the service of the ocean. This year, Portugal is the guest country for the event, which guarantees free registration for Portuguese participants. The STW40 workshop, one of the workshops proposed and selected for inclusion in the event's official programme, forms part of the ALGAPROTEC project (LGC & LNEG), a bilateral cooperation initiative between France and Portugal, funded by the CNRS IRP programme (International Research Project).

LGC Group
Feb 26th, 2026
LGC Group strengthens its reference material portfolio and North American reach with the acquisition of the ChromaDex Reference Standards business

LGC Group strengthens its reference material portfolio and North American reach with the acquisition of the ChromaDex Reference Standards business. The acquisition further enhances LGC's ability to support pharmaceutical, food, and testing laboratories with trusted reference materials that underpin safety, quality, and regulatory confidence. London, UK, 26 February 2026. LGC Group, a global leader in life sciences, diagnostics, and analytical solutions, today announced the acquisition of the ChromaDex Reference Standards portfolio from Niagen Bioscience (NASDAQ: NAGE). The acquisition expands LGC's reference materials offering and strengthens its commercial reach across North America. The acquisition brings an established portfolio of phytochemical reference materials for the dietary supplements industry into LGC, enabling direct engagement with a broad base of laboratory customers and strengthening LGC's ability to support pharmaceutical companies, testing laboratories, and food producers operating in regulated markets. Bruno Rossi, EVP & General Manager, LGC Standards, said: "The ChromaDex standards portfolio further enhances LGC's ability to support our pharmaceutical customers, testing laboratories, and food producers. Building on LGC's position as a world leader in reference materials and analytical standards, this acquisition expands our North American commercial reach and further supports customers in generating reliable data that safeguards product integrity and confidence across global supply chains." For over 25 years, the ChromaDex Reference Standards portfolio has been built on deep expertise in phytochemical characterisation and analytical verification. The portfolio includes over 3,000 phytochemical reference materials, spanning major classes such as alkaloids, flavonoids, terpenes, carotenoids, organic acids, stilbenoids, vitamins, and select botanicals and plant-based compounds. These materials are widely used to support ingredient verification, method development, authenticity testing, contamination detection, and routine quality control across complex global supply chains. Rob Fried, CEO of Niagen Bioscience, remarked, "This transaction reflects our disciplined focus on what we do best - advancing NAD+ science and delivering clinically proven, patented Niagen(R) solutions across consumer and clinical channels. Selling Reference Standards to LGC is a meaningful step in simplifying our business and ensuring we are allocating capital and talent toward the highest-impact opportunities for shareholders." The acquisition of the ChromaDex Reference Standards portfolio demonstrates LGC's commitment to providing trusted reference materials and measurement solutions that reinforce product safety, quality, and regulatory confidence, advancing its mission of Science for a Safer World. LGC is a global leader in life sciences, diagnostics, and analytical solutions. LGC Group work with partners around the world to address some of society's most important challenges, from diagnosing disease and enabling new treatments to supporting food security and protecting public health. Its science supports discovery, enables better health outcomes and helps safeguard the integrity of food, water, medicines and the environment. Every day, LGC Group provide the components, standards and services that laboratories, manufacturers and regulators rely on to make confident, evidence-based decisions. With operations in 14 countries and more than 180 years of scientific expertise, its work supports public health and sustainability at a global scale. From improving the accuracy of medical testing and verifying the safety of food products, to helping scientists develop the next generation of medicines, its solutions are trusted by customers in more than 170 countries. For further information please contact: Customer contact: Richard Pembrey Sales Director, LGC Standards +1 603 851 2834 Media contact: Magda Bartoszewicz Director Corporate Brand and Communications, LGC Group +44 7408 850 514

CHEManager
Sep 12th, 2025
LGC Opens $100 Million Pharma Synthesis Center in Canada

LGC Group has inaugurated a CAD$100 million (€61.5 million) Organic Chemistry Synthesis Centre of Excellence in Vaughan, canada, significantly expanding global capacity for advanced research chemicals to support the pharmaceutical and life sciences sectors.

GBJ Plastering
Apr 15th, 2025
Ensuring Precision in Analysis: Graham B Jackson Pty Ltd Supply of LGC Certified Reference Materials

Graham B Jackson Pty Ltd (GBJPL), an Australian leader in reference materials, partners with the globally renowned LGC Group to supply high-quality CRMs to laboratories across the country.